Y-mAbs Therapeutics, Inc. earnings per share and revenue

YMAB earnings per share for the last quarter are -0.21 USD whereas the estimation was -0.12 USD which accounts for -68.97% surprise. Company revenue for the same period amounts to 22.80 M USD despite the estimated figure of 23.02 M USD. Estimated earnings per share for the next quarter are -0.16 USD, and revenue is expected to reach 23.28 M USD. Also watch annual changes over time to get a bigger picture of YMAB earnings per share and revenue dynamics.